Digital Health Venture Partners: Company Profile

Background

Overview

Digital Health Venture Partners (DHVP) is a seed-stage venture capital firm based in Washington, D.C., dedicated to transforming healthcare through strategic investments in early-stage healthcare software and technology-enabled services companies. Founded in 2023, DHVP focuses on partnering with resilient, mission-driven teams to address complex challenges in the healthcare sector.

Mission and Vision

DHVP's mission is to empower the future of healthcare by investing in innovative solutions that enhance patient care, improve outcomes, and reduce costs. The firm's vision is to reshape healthcare by leveraging data, artificial intelligence (AI), and policy advancements to create a more efficient and accessible system.

Primary Area of Focus

DHVP specializes in investing in healthcare companies that develop durable solutions across software (AI & SaaS), AI-enabled services, and consumerism. The firm takes a thematic approach, focusing on:

Unlocking Healthcare Data: Transforming fragmented and inaccessible data into actionable insights to drive better decision-making across the healthcare system.

Operationalizing AI to Streamline Workflows: Applying AI to automate and optimize back-office and operational workflows, reducing administrative burdens and improving care delivery efficiency.

Activating Policy Tailwinds: Capitalizing on policy and regulatory shifts that unlock new healthcare business models, including data accessibility, value-based care infrastructure, and innovations in payment and reimbursement models.

Industry Significance

As a value-add venture capital firm, DHVP plays a crucial role in fostering innovation within the healthcare industry. By supporting early-stage companies, DHVP contributes to the development of solutions that address pressing healthcare challenges, thereby enhancing the overall quality and efficiency of care.

Key Strategic Focus

Core Objectives

DHVP aims to:

Identify and invest in early-stage healthcare companies with innovative solutions.

Provide strategic capital and operational support to portfolio companies.

Facilitate partnerships and collaborations that accelerate growth and market adoption.

Specific Areas of Specialization

The firm focuses on:

Healthcare Software (AI & SaaS): Investing in companies that develop software solutions leveraging AI to improve healthcare delivery.

AI-Enabled Services: Supporting services that utilize AI to enhance operational efficiency and patient outcomes.

Healthcare Consumerism: Backing companies that empower consumers to take an active role in their healthcare decisions.

Key Technologies Utilized

DHVP emphasizes investments in technologies such as:

Artificial Intelligence (AI): For data analysis, decision support, and workflow optimization.

Software as a Service (SaaS): Providing scalable and accessible healthcare solutions.

Data Analytics: Transforming healthcare data into actionable insights.

Primary Markets or Conditions Targeted

The firm targets:

Healthcare Providers: Hospitals, clinics, and other care facilities seeking operational improvements.

Patients: Individuals looking for enhanced healthcare experiences and outcomes.

Payers: Insurance companies and other entities interested in cost-effective care solutions.

Financials and Funding

Funding History

As a seed-stage venture capital firm, DHVP has made several investments in early-stage healthcare companies. The firm's most recent investment was in Brellium, an AI-powered clinical compliance platform, which raised a Series A round in 2025.

Total Funds Raised

Specific details regarding the total funds raised by DHVP are not publicly disclosed.

Notable Investors

DHVP's investors include leading healthcare founders, executives, private equity investors, funds of funds, and family offices, many of whom have direct ties to the healthcare industry, providing valuable support to portfolio companies.

Intended Utilization of Capital

The capital raised is utilized to:

Invest in early-stage healthcare companies.

Provide strategic guidance and operational support to portfolio companies.

Facilitate partnerships and collaborations that accelerate growth and market adoption.

Pipeline Development

Key Pipeline Candidates

DHVP's portfolio includes companies such as:

ArcHouse: A healthcare technology company that streamlines hospice operations with an all-in-one platform for admissions, documentation, and patient monitoring.

Avo: Transforms evidence into actionable tools in the clinical workflow to standardize care and reduce burnout.

BeHuman Health: Offers AI-driven, insurance-covered cancer screenings, including genetic testing and in-home kits, to make early detection simple, accessible, and proactive.

Big Leap Health: Connects patients with certified clinics offering insurance-covered, advanced mental health treatments such as Spravato (esketamine) and Transcranial Magnetic Stimulation (TMS).

Brellium: An AI-powered clinical compliance platform that automates medical chart audits, ensuring accurate documentation and reducing administrative burdens for healthcare providers.

Stages of Clinical Trials or Product Development

Specific details regarding the stages of clinical trials or product development for these companies are not publicly disclosed.

Target Conditions

The portfolio companies target various conditions, including:

Cancer: Through early detection and screening solutions.

Mental Health: By providing advanced treatment options.

Hospice Care: By streamlining operations and improving patient monitoring.

Relevant Timelines for Anticipated Milestones

Specific timelines for anticipated milestones are not publicly disclosed.

Technological Platform and Innovation

Proprietary Technologies

DHVP's portfolio companies develop proprietary technologies such as:

AI-Powered Platforms: For clinical compliance and operational optimization.

Integrated Healthcare Solutions: Combining various aspects of patient care and monitoring.

Significant Scientific Methods

The companies employ methods including:

Clinical Workflow Integration: To standardize care and reduce burnout.

AI-Driven Diagnostics: For early detection and proactive care.

AI-Driven Capabilities

The portfolio companies utilize AI to:

Automate Administrative Tasks: Reducing the burden on healthcare providers.

Enhance Decision-Making: By providing actionable insights from data.

Personalize Patient Care: Through tailored treatment plans and monitoring.

Leadership Team

Key Executive Profiles

Arvin Grover: Founder & General Partner.

Steve Yaskin: Partner.

Dan Cimaglia: Scout.

Dennis Cardoza: Advisor.

Eric Hargan: Advisor.

Professional Backgrounds and Contributions

Specific details regarding the professional backgrounds and contributions of the leadership team are not publicly disclosed.

Competitor Profile

Market Insights and Dynamics

The digital health venture capital landscape is characterized by:

Growing Investment: Digital health funding reached $10.1 billion in 2024, with a focus on earlier-stage dealmaking.

Concentration of Deals: A few large, more established players dominate healthcare innovation headlines, with mega funds like Andreessen Horowitz and General Catalyst leading the transaction count.

Competitor Analysis

Key competitors in the digital health venture capital space include: